Our results indicated that inhibition of SOD1 prevents BM-MSCs from rescuing neuropathy in a paracrine manner, which suggests that SOD1 could be a major part of their neuroprotective mechanism of action along with their ability to reduce inflammation and plexitis. Here, SOD1 is linked to neuropathy.